Key facts
- Innerskin’s last known valuation is $47.4M (Nov 2023).
- It has raised $23.4M; the latest was Early Stage VC ($15.0M) in Dec 2025.
- Notable investors include The Carle Foundation, Capital First Partners, IRIS Ventures (Spain), Label Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Innerskin
- ·The full record, as it builds
Funding rounds
No funding rounds for Innerskin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Innerskin
Provider of medical skincare products and treatments intended to help patients improve their skin health and appearance. The company offers a variety of treatments, including laser hair removal, wrinkle reduction, and skin tightening, enabling people to access personalized care performed by experienced doctors.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2022
- Employees
- 21
- Website
- innerskin.com/
- Ownership
- Privately Held (backing)
Innerskin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innerskin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innerskin in its N-PORT filings yet. We sweep new filings monthly.